Reliability and validity of a pointof-care sural nerve conduction device for identification of diabetic neuropathy. PLoS One 9:e86515

Background: Confirmation of diabetic sensorimotor polyneuropathy (DSP) relies on standard nerve conduction studies (NCS) performed in specialized clinics. We explored the utility of a point-of-care device (POCD) for DSP detection by nontechnical personnel and a validation of diagnostic thresholds with those observed in a normative database. Research Design and Methods: 44 subjects with type 1 and type 2 diabetes underwent standard NCS (reference method). Two nontechnical examiners measured sural nerve amplitude potential (SNAP) and conduction velocity (SNCV) using the POCD. Reliability was determined by intraclass correlation coefficients (ICC [2,1]). Validity was determined by Bland-Altman analysis and receiver operating characteristic curves. Results: The 44 subjects (50 % female) with mean age 56618 years had mean SNAP and SNCV of 8.068.6 mV and 41.568.2 m/s using standard NCS and 8.068.2 mV and 49.9611.1 m/s using the POCD. Intrarater reproducibility ICC values were 0.97 for SNAP and 0.94 for SNCV while interrater reproducibility values were 0.83 and 0.79, respectively. Mean bias of the POCD was20.163.6 mV for SNAP and +8.466.4 m/s for SNCV. A SNAP of #6 mV had 88 % sensitivity and 94 % specificity for identifying age-and height-standardized reference NCS values, while a SNCV of #48 m/s had 94 % specificity and 82% sensitivity. Abnormality in one or more of these thresholds was associated with 95 % sensitivity and 71 % specificity for identification of DSP according to electrophysiological criteria